Skip to main content

Moderna's Covid-19 vaccine will reportedly be reviewed by WHO this week

The Covid-19 vaccine made by Cambridge biotech Moderna Inc. will be reviewed on April 30 by the World Health Organization for possible emergency listing, according to a report by Reuters.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.